Institutional Review Board
Determining what activities are overseen by the IRB
Click on the heading below to search the page:
If the activity is RESEARCH and involves HUMAN SUBJECTS, an IRB application is required for review and approval.
Research: a systematic investigation, including research development, testing and evaluation, designed to develop or contribute to generalizable knowledge
Systematic Investigation: an activity that involves a prospective plan that incorporates data collection, either quantitative or qualitative, and data analysis to answer a question.
Generalizable Knowledge: designed to draw general conclusions, inform policy, or generalize findings beyond a single individual or an internal program (e.g., publications or presentations). However, research results do not have to be published or presented to qualify the experiment or data gathering as research. The intent to contribute to "generalizable (scholarly) knowledge" makes an experiment or data collection research, regardless of publication.
Human Subject:A living individual about whom an investigator (whether professional or student) conducting
research (1) obtains information or biospecimens through intervention or interaction with the individual, and uses, studies, or analyzes the information or biospecimens, or (2) obtains, uses analyzes, or generates identifiable private information or identifiable biospecimens.
Intervention: includes both physical procedures by which data are gathered (for example, venipuncture) and manipulations of the subject or the subject's environment that are performed for research purposes.
Interaction: includes communication or interpersonal contact between investigator and subject.
Private information: includes information about behavior that occurs in a context in which an individual can reasonably expect that no observation or recording is taking place, and information which has been provided for specific purposes by an individual and which the individual can reasonably expect will not be made public (for example, a medical record). Identifiable private information is private information for which the identity of the subject is or may readily be ascertained by the investigator or associated with the information. An identifiable biospecimen is a biospecimen for which the identity of the subject is or may readily be ascertained by the investigator or associated with the biospecimens.
Clinical investigation: means any experiment that involves a test article and one or more human subjects and that either is subject to requirements for prior submission to the Food and Drug Administration under section 505(i) or 520(g) of the act, or is not subject to requirements for prior submission to the Food and Drug Administration under these sections of the act, but the results of which are intended to be submitted later to, or held for inspection by, the Food and Drug Administration as part of an application for a research or marketing permit. The term does not include experiments that are subject to the provisions of part 58 of this chapter, regarding nonclinical laboratory studies.
Human subject: means an individual who is or becomes a participant in research, either as a recipient of the test article or as a control. A subject may be either a healthy human or a patient.
If any item below is true, it is research requiring IRB review:
- The activity involves the use of a drug other than the use of a marketed drug in the course of medical practice.
- The activity involves the use of a medical device to evaluate safety or effectiveness of the device.
- The results will be submitted to the FDA or held for inspection by the FDA.
- Tissue specimens are being used to test the effectiveness of a medical device where the data will be submitted to or held for inspection by FDA in support of a marketing application.
- The activity involves FDA regulated articles, food or dietary supplements that bear a nutrient content or a health claim, a food or color additive for human consumption, infant formula, biological or electronic product for human use, or other article subject to the FD&C Act.
- The activity involves a retrospective chart review of outcomes of patients on a certain drug or device in the course of medical practice where the data will be submitted to or held for inspection by the FDA in support of a marketing application.
- The activity involves a prospective study of the outcomes of patients who were prescribed a drug or device by their personal physicians, or compares the diagnostic results of scans or tests ordered by their personal physicians where the data will be submitted to or held for inspection by the FDA in support of a marketing application.
- Individuals will participate in an intervention either as subjects or as controls.
- Investigational devices are being used on subjects or their specimens.
If the research is supported or sponsored by the Department of Defense and involves non-exempt classified research, it must be conducted following the requirements of Instruction 3216.02.13. See the Department of Defense IRB policy for more information.
- If you are unsure whether your project requires IRB review, complete and submit the Human Subjects Research Determination Form in eCompliance. A decision from the IRB office will be promptly communicated to you.
- A list of applications can be found in eCompliance under the IRB Forms link. If you have questions about which application to complete, contact the IRB office at 573.882.3181 or email email@example.com.
Some activities are overseen by the IRB, but are not considered research. These include:
- Case Reports – a single retrospective case report of 3 or less individuals
- Humanitarian Use Device – request to use a humanitarian use device
- Quality Improvement – quality improvement studies, need-assessments, customer satisfaction surveys (this form is not required for submission, but the PI may need this determination documented)
- See Initial Review SOP for additional information.